Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Operating Leases (2020 - 2025)

Historic Operating Leases for Adma Biologics (ADMA) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • Adma Biologics' Operating Leases rose 600.11% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 600.11%. This contributed to the annual value of $8.6 million for FY2024, which is 1245.53% down from last year.
  • As of Q3 2025, Adma Biologics' Operating Leases stood at $9.4 million, which was up 600.11% from $9.3 million recorded in Q2 2025.
  • Adma Biologics' Operating Leases' 5-year high stood at $10.9 million during Q2 2022, with a 5-year trough of $7.3 million in Q1 2022.
  • In the last 5 years, Adma Biologics' Operating Leases had a median value of $9.3 million in 2025 and averaged $9.2 million.
  • Per our database at Business Quant, Adma Biologics' Operating Leases surged by 7217.65% in 2021 and then tumbled by 1253.29% in 2025.
  • Quarter analysis of 5 years shows Adma Biologics' Operating Leases stood at $7.5 million in 2021, then skyrocketed by 43.44% to $10.7 million in 2022, then fell by 8.64% to $9.8 million in 2023, then decreased by 12.46% to $8.6 million in 2024, then grew by 9.77% to $9.4 million in 2025.
  • Its Operating Leases stands at $9.4 million for Q3 2025, versus $9.3 million for Q2 2025 and $8.3 million for Q1 2025.